A triple combination of treatments on moderate COVID-19

A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent.

Guardado en:
Detalles Bibliográficos
Autores principales: Bao ChunMiao, Li BinBin, Zhou YuFeng
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
R
Acceso en línea:https://doaj.org/article/e6b38afe68524efaa9227a695bd93682
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e6b38afe68524efaa9227a695bd93682
record_format dspace
spelling oai:doaj.org-article:e6b38afe68524efaa9227a695bd936822021-12-05T14:10:54ZA triple combination of treatments on moderate COVID-192391-546310.1515/med-2021-0279https://doaj.org/article/e6b38afe68524efaa9227a695bd936822021-05-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0279https://doaj.org/toc/2391-5463A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent.Bao ChunMiaoLi BinBinZhou YuFengDe Gruyterarticlesars-cov-2covid-19length of stayvirus sheddingpneumoniaMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 769-772 (2021)
institution DOAJ
collection DOAJ
language EN
topic sars-cov-2
covid-19
length of stay
virus shedding
pneumonia
Medicine
R
spellingShingle sars-cov-2
covid-19
length of stay
virus shedding
pneumonia
Medicine
R
Bao ChunMiao
Li BinBin
Zhou YuFeng
A triple combination of treatments on moderate COVID-19
description A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent.
format article
author Bao ChunMiao
Li BinBin
Zhou YuFeng
author_facet Bao ChunMiao
Li BinBin
Zhou YuFeng
author_sort Bao ChunMiao
title A triple combination of treatments on moderate COVID-19
title_short A triple combination of treatments on moderate COVID-19
title_full A triple combination of treatments on moderate COVID-19
title_fullStr A triple combination of treatments on moderate COVID-19
title_full_unstemmed A triple combination of treatments on moderate COVID-19
title_sort triple combination of treatments on moderate covid-19
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/e6b38afe68524efaa9227a695bd93682
work_keys_str_mv AT baochunmiao atriplecombinationoftreatmentsonmoderatecovid19
AT libinbin atriplecombinationoftreatmentsonmoderatecovid19
AT zhouyufeng atriplecombinationoftreatmentsonmoderatecovid19
AT baochunmiao triplecombinationoftreatmentsonmoderatecovid19
AT libinbin triplecombinationoftreatmentsonmoderatecovid19
AT zhouyufeng triplecombinationoftreatmentsonmoderatecovid19
_version_ 1718371633183326208